[Improved knowledge resulted in better care of ALS]

Area of Science:

• Neurology
• Pharmacology

Context:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease.
• Recent years have seen significant progress in understanding and managing ALS.

Purpose:

• To review recent advancements in the understanding of ALS pathogenic mechanisms.
• To summarize updated diagnostic and therapeutic strategies for ALS patients.

Summary:

• Riluzole, introduced in 1996, was the first drug with a verified effect on ALS disease progression.
• The review encompasses novel insights into the molecular pathways underlying ALS.
• Current diagnostic criteria and evolving treatment protocols are discussed.

Impact:

• Provides a comprehensive overview of the current state of ALS research and clinical practice.
• Highlights the importance of Riluzole and other therapeutic developments in improving patient outcomes.
• Serves as a valuable resource for clinicians and researchers in the field of neurodegenerative diseases.